医学信息2016，Vol.29Issue(33)：293-294,2.
替比夫定、阿德福韦酯联用与恩替卡韦单药治疗失代偿期乙肝肝硬化疗效对比观察
Telbivudine Combined with Adefovir and Entecavir Monotherapy for Treatment of Decompensated Hepatitis B Cirrhosis Comparison
温婧 1杨林1
作者信息
- 1. 双楠医院消化科，四川 成都 610047
- 折叠
摘要
Abstract
Objective To explore the combined with entecavir monotherapy compared with decompensated hepatitis B cirrhosis of telbivudine and adefovir dipivoxil.Methods 98 cases of patients with cirrhosis of the liver cirrhosis were randomly divided into two groups.Results The observation group patients were all due to the control group.Conclusion With entecavir monotherapy in the treatment of decompensated hepatitis B cirrhosis were significantly associated with telbivudine and adefovir dipivoxil.关键词
替比夫定/阿德福韦酯/恩替卡韦Key words
Telbivudine/Adefovir dipivoxil/Entecavir引用本文复制引用
温婧,杨林..替比夫定、阿德福韦酯联用与恩替卡韦单药治疗失代偿期乙肝肝硬化疗效对比观察[J].医学信息,2016,29(33):293-294,2.
